Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

43.39 +1.34 (+3.19%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna Inc

< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
99 100 Next >
US Stock Futures Dip As Apple, Amazon Earnings Loom: Analyst Warns Of 'Perfectly Normal' 5% Pullback This Month
Stocks appear to be entrenched in an August swoon and it remains to be seen if big tech earnings provide a boost. 
Via Benzinga
Moderna Reports Second Quarter 2023 Financial Results and Provides Business Updates
Via ACCESSWIRE
3 ‘Strong Buy’ Biotech Stocks You Should Be Loading Up On Now
Biotech stocks can be a lucrative investment opportunity, these three biotech stocks to buy now are among analyst favorites. 
Via InvestorPlace
Check Out What Whales Are Doing With MRNA
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 46 stocks hit new 52-week lows. 
Via Benzinga
3 Cheap Healthcare Stocks That Smart Investors Will Snap Up Now
These underperforming companies have attractive valuations and long-term potential that investors shouldn't ignore. 
Via InvestorPlace
Why Novavax Stock Zoomed 13% Higher on Monday
A renewed fight against COVID-19 might be coming. 
Via The Motley Fool
7 Stocks to Buy Before They Surpass 2021 Highs
These 7 stocks to watch before new peaks are approaching 2021 highs and should move past those levels sometime this year. 
Via InvestorPlace
Merck Q2 Earnings Preview: Analyst Expectations, Jim Cramer's View, And The Spotlight On Keytruda
Pharmaceutical company Merck & Company (NYSE: MRK) reports second quarter financial results before market open Tuesday. 
Via Benzinga
Accenture, Hewlett Packard Enterprise And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed higher on Friday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $6,400 Today
Via Benzinga
Moderna Unusual Options Activity For July 25
Via Benzinga
Where Moderna Stands With Analysts
Via Benzinga
7 Healthcare Stocks to Ditch Before They Make Your Portfolio Sick
For investors who choose wisely, profits in healthcare stocks can be spectacular. But the losses can also be dramatic if you choose poorly. 
Via InvestorPlace
As COVID-19 Cases Spike This Summer, Healthcare Experts See It As Recurring Theme And Recommend These Measures
Via Benzinga
Earnings This Week: Apple, Amazon And AMD
It is another busy week for earnings. 
Via Talk Markets
Cathie Wood Is Buying Up Shares of This Beaten-Down Biotech. Should You?
Moderna shares have declined over the past year amid concerns about post-pandemic vaccine sales. 
Via The Motley Fool
Individualized Cancer Treatment: Merck/Moderna's Personalized Skin Cancer Therapy Enters Late-Stage Of Development
Merck & Co Inc (NYSE: MRK) and Moderna Inc (NASDAQ: MRNA) initiated a pivotal Phase 3 randomized V940-001 trial evaluating V940 (mRNA-4157), an investigational individualized neoantigen therapy (INT),... 
Via Benzinga
Check Out What Whales Are Doing With MRNA
Via Benzinga
Merck and Moderna Initiate Phase 3 Study Evaluating V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) for Adjuvant Treatment of Patients with Resected High-Risk (Stage IIB-IV) Melanoma
From Merck & Co., Inc.
Via Business Wire
Moderna On Cathie Wood's Radar Ahead Of Q2 Results: Ark Boosts Stake In COVID-19 Vaccine Maker By $12M This Week
Cathie Wood's Ark Invest bought over $12 million worth of Moderna shares as the biopharma expands its pipeline beyond COVID-19. 
Via Benzinga
Cathie Wood's Ark Invest Makes Major Moves In This Warren Buffett-Backed EV Company, Moderna
Via Benzinga
The 3 Most Undervalued Biotech Stocks to Buy Now: July 2023
These three undervalued biotech stocks could have plenty of room to run if their efforts to push out promising pipeline drugs are successful. 
Via InvestorPlace
Fentanyl Crisis In US: Biden Administration Contemplates Easing Sanctions on China's Forensic Institute
The Biden administration is reportedly considering lifting sanctions on a Chinese forensic institute allegedly involved in human rights violations. The U.S. is striving to find a way to persuade... 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Analyst Initiates Arcturus: Sees Attractive Growth Trajectory with Vaccine Franchise Despite Competition
William Blair analyst Myles Minter has initiated coverage of Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) with an Outperform rating and a fair  
Via Benzinga
Moderna Is Fairly Valued, Balancing Declining COVID-19 Base Business with Promising Future Pipeline: Analyst
William Blair initiated coverage on Moderna Inc (NASDAQ: MRNA) with a Market Perform rati 
Via Benzinga
Obey the Sell Signals: 3 Blue-Chip Stocks to Let Go
The recent rally is starting to extend to include large-cap and blue-chip stocks, but there are still some blue-chip stocks to avoid. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For July 24, 2023
Via Benzinga
Coinbase Global, Moderna And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed higher on Tuesday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.